Psychosocial Factors of Suicidal and Self-Harm Behavior among Women with Perinatal Mental Illness
Not Applicable
- Conditions
- Health Condition 1: F411- Generalized anxiety disorderHealth Condition 2: F320- Major depressive disorder, singleepisode, mildHealth Condition 3: F422- Mixed obsessional thoughts and actsHealth Condition 4: F413- Other mixed anxiety disorders
- Registration Number
- CTRI/2024/03/063858
- Lead Sponsor
- Rigzen Angmo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Women with common mental disorders visiting the perinatal clinic at NIMHANS
2. New onset or exacerbation of mental illness during pregnancy or postpartum
3. Women who consent and are willing to participate in the study
4. Women between the age of 18-35 years
5. Women who speak Hindi, English and Kannada
Exclusion Criteria
1. Women with perinatal mental illness secondary to comorbid medical or neurological conditions, Mental retardation, or Organic psychiatric illness.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1 Suicide and selfharm among women with CMD during the perinatal period. <br/ ><br>2 Compare suicidal and self-harm behavior among women with CMD during the perinatal period and women with CMD during the non-perinatal period. <br/ ><br>3 Find out the predictors of suicidal and self-harm behavior among women with CMD during the perinatal periodTimepoint: BASELINE ASSESSMENT
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What neurobiological pathways link psychosocial stressors to suicidal ideation in perinatal women with F411 and F320?
How do cognitive-behavioral therapy and interpersonal therapy compare in reducing self-harm behaviors among perinatal mental illness patients?
Which biomarkers, such as cortisol or inflammatory cytokines, predict suicidal risk in women with F422 and F413 perinatal mental illness?
What are effective management strategies for high-risk perinatal women with suicidal tendencies identified in observational studies?
How do SSRIs and SNRIs interact with psychosocial interventions in treating perinatal depression and anxiety linked to self-harm?